{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:38:08Z","timestamp":1792787888955,"version":"4.5.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,20]],"date-time":"2023-09-20T00:00:00Z","timestamp":1695168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,20]],"date-time":"2023-09-20T00:00:00Z","timestamp":1695168000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Hefei Municipal Health Commission Applied Medical Research Project","award":["Hwk2020zd002"],"award-info":[{"award-number":["Hwk2020zd002"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Community-acquired pneumonia (CAP) patients usually present with parapneumonic pleural effusion (PPE), which complicates the treatment of pneumonia. This study aims to investigate the clinical characteristics and risk factors of elderly CAP patients hospitalised with PPE.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The clinical data of 132 elderly patients with CAP were retrospectively analysed. A total of 54 patients with PPE (PPE group) and 78 patients without PPE (NPPE group) were included in this study. Clinical data, laboratory examinations, treatments and other relevant indicators were collected. Univariate analysis and multivariate logistic regression analysis will be used to explore the possible risk factors for PPE.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The proportion of PPE in elderly patients with CAP was 40.9%. PPE patients were significantly more likely to be older, have comorbid neurological diseases, experience chest tightness, and have a lasting fever (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.05). In contrast to NPPE patients, the total number of lymphocytes, serum albumin and blood sodium levels in the PPE group were significantly lower (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.05). The blood D-dimer, C-reactive protein and CURB-65 score of PPE patients were significantly higher (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.05) than those of NPPE patients. Multivariate logistic regression identified chest tightness (OR\u2009=\u20093.964, 95% CI: 1.254\u201312.537,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.019), long duration of fever (OR\u2009=\u20091.108, 95%CI: 1.009\u20131.217,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.03), low serum albumin (OR\u2009=\u20090.876, 95%CI: 0.790\u2013 0.971,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.012) or low blood sodium (OR\u2009=\u20090.896, 95%CI: 0.828\u20130.969,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.006) as independently associated with the development of parapneumonic pleural effusion in the elderly.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study has identified several clinical factors, such as chest tightness, long duration of fever, low serum albumin, and low blood sodium, as risk factors for the development of pleural effusion in elderly patients with CAP. Early identification and prompt management of these patients can prevent inappropriate treatment and reduce morbidity and mortality.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12890-023-02649-4","type":"journal-article","created":{"date-parts":[[2023,9,20]],"date-time":"2023-09-20T10:01:49Z","timestamp":1695204109000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Analysis of clinical characteristics and risk factors of community-acquired pneumonia complicated by parapneumonic pleural effusion in elderly patients"],"prefix":"10.1186","volume":"23","author":[{"given":"Mingmei","family":"Zhong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiqin","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huizhen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangyang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,20]]},"reference":[{"issue":"5","key":"2649_CR1","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1055\/s-0038-1676361","volume":"35","author":"W Bremer","year":"2018","unstructured":"Bremer W, Ray CE Jr. A primer on the management of pleural effusions. Semin Intervent Radiol. 2018;35(5):486\u201391.","journal-title":"Semin Intervent Radiol"},{"issue":"11","key":"2649_CR2","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1086\/522996","volume":"45","author":"SA Sahn","year":"2007","unstructured":"Sahn SA. Diagnosis and management of parapneumonic effusions and empyema. Clin Infect Dis. 2007;45(11):1480\u20136.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"2649_CR3","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1164\/ajrccm\/148.3.813","volume":"148","author":"SA Sahn","year":"1993","unstructured":"Sahn SA. Management of complicated parapneumonic effusions. Am Rev Respir Dis. 1993;148(3):813\u20137.","journal-title":"Am Rev Respir Dis"},{"key":"2649_CR4","unstructured":"Chen C, Han X, Liu X. Clinical characteristics and analysis of community-acquired pneumonia complicated with pleural effusion. Chin J Respir Crit Care Med. 2021;20(08):549\u201357. (In Chinese)."},{"key":"2649_CR5","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/2049-6958-9-49","volume":"9","author":"A G\u00fcm\u00fcs","year":"2014","unstructured":"G\u00fcm\u00fcs A, Ozkaya S, Ozyurt S, et al. A novel biomarker in the diagnosis of parapneumonic effusion: neutrophil gelatinase-associated lipocalin. Multidiscip Respir Med. 2014;9:49.","journal-title":"Multidiscip Respir Med"},{"issue":"4","key":"2649_CR6","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1258\/004947507782333152","volume":"37","author":"S Mohanty","year":"2007","unstructured":"Mohanty S, Kapil A, Das BK. Bacteriology of parapneumonic pleural effusions in an Indian hospital. Trop Doct. 2007;37(4):228\u20139.","journal-title":"Trop Doct"},{"issue":"5","key":"2649_CR7","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1183\/09031936.00000211","volume":"38","author":"M Falguera","year":"2011","unstructured":"Falguera M, Carratal\u00e0 J, Bielsa S, et al. Predictive factors, microbiology and outcome of patients with parapneumonic effusion. Eur Respir J. 2011;38(5):1173\u20139.","journal-title":"Eur Respir J"},{"issue":"7","key":"2649_CR8","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1136\/thx.2008.105080","volume":"64","author":"JD Chalmers","year":"2009","unstructured":"Chalmers JD, Singanayagam A, Murray MP, et al. Risk factors for complicated parapneumonic effusion and empyema on presentation to hospital with community-acquired pneumonia. Thorax. 2009;64(7):592\u20137.","journal-title":"Thorax"},{"issue":"6","key":"2649_CR9","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1016\/j.chest.2015.12.027","volume":"149","author":"NC Dean","year":"2016","unstructured":"Dean NC, Griffith PP, Sorensen JS, et al. Pleural Effusions at First ED Encounter Predict Worse Clinical Outcomes in Patients With Pneumonia. Chest. 2016;149(6):1509\u201315.","journal-title":"Chest"},{"issue":"12","key":"2649_CR10","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.arbres.2015.01.009","volume":"51","author":"L Ferreiro","year":"2015","unstructured":"Ferreiro L, San Jos\u00e9 ME, Vald\u00e9s L. Management of Parapneumonic pleural effusion in adults. Arch Bronconeumol. 2015;51(12):637\u201346.","journal-title":"Arch Bronconeumol"},{"issue":"5","key":"2649_CR11","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1007\/s00408-018-0146-2","volume":"196","author":"S Touray","year":"2018","unstructured":"Touray S, Sood RN, Lindstrom D, et al. Risk stratification in patients with complicated Parapneumonic effusions and empyema using the RAPID Score. Lung. 2018;196(5):623\u20139.","journal-title":"Lung"},{"issue":"43","key":"2649_CR12","doi-asserted-by":"publisher","first-page":"e17397","DOI":"10.1097\/MD.0000000000017397","volume":"98","author":"DB Fitzgerald","year":"2019","unstructured":"Fitzgerald DB, Waterer GW, Read CA, et al. Steroid therapy and outcome of parapneumonic pleural effusions (STOPPE): Study protocol for a multicenter, double-blinded, placebo-controlled randomized clinical trial. Medicine (Baltimore). 2019;98(43):e17397.","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"2649_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.21037\/atm.2018.11.44","volume":"7","author":"D Li","year":"2019","unstructured":"Li D, Shen Y, Qin J, et al. Diagnostic performance of C-reactive protein for parapneumonic pleural effusion: a meta-analysis. Ann Transl Med. 2019;7(1):1.","journal-title":"Ann Transl Med"},{"issue":"1","key":"2649_CR14","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1378\/chest.13-1912","volume":"145","author":"M S\u00f8gaard","year":"2014","unstructured":"S\u00f8gaard M, Nielsen RB, N\u00f8rgaard M, et al. Incidence, length of stay, and prognosis of hospitalized patients with pleural empyema: a 15-year Danish nationwide cohort study. Chest. 2014;145(1):189\u201392.","journal-title":"Chest"},{"issue":"4","key":"2649_CR15","first-page":"241","volume":"39","author":"Respiratory Diseases Branch","year":"2016","unstructured":"Respiratory Diseases Branch, Chinese Medical Association. Guidelines for the diagnosis and treatment of adult community acquired pneumonia in China (2016 Edition). Zhonghua Jie He He Hu Xi Za Zhi. 2016;39(4):241\u20132 (In Chinese).","journal-title":"Zhonghua Jie He He Hu Xi Za Zhi"},{"issue":"2021","key":"2649_CR16","first-page":"8024024","volume":"11","author":"Q Ren","year":"2021","unstructured":"Ren Q, Liu H, Wang Y, et al. The Role of Red Blood Cell Distribution Width in the Severity and Prognosis of Community-Acquired Pneumonia. Can Respir J. 2021;11(2021):8024024.","journal-title":"Can Respir J"},{"issue":"4","key":"2649_CR17","doi-asserted-by":"publisher","first-page":"R141","DOI":"10.1186\/cc11447","volume":"16","author":"C Marti","year":"2012","unstructured":"Marti C, Garin N, Grosgurin O, et al. Prediction of severe community-acquired pneumonia: a systematic review and meta-analysis. Crit Care. 2012;16(4):R141.","journal-title":"Crit Care"},{"issue":"1","key":"2649_CR18","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12890-018-0587-7","volume":"18","author":"RX Dai","year":"2018","unstructured":"Dai RX, Kong QH, Mao B, et al. The mortality risk factor of community acquired pneumonia patients with chronic obstructive pulmonary disease: a retrospective cohort study. BMC Pulm Med. 2018;18(1):12.","journal-title":"BMC Pulm Med"},{"issue":"10","key":"2649_CR19","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1080\/14656566.2017.1340940","volume":"18","author":"D Viasus","year":"2017","unstructured":"Viasus D, N\u00fa\u00f1ez-Ramos JA, Viloria SA, et al. Pharmacotherapy for community-acquired pneumonia in the elderly. Expert Opin Pharmacother. 2017;18(10):957\u201364.","journal-title":"Expert Opin Pharmacother"},{"key":"2649_CR20","doi-asserted-by":"publisher","first-page":"106553","DOI":"10.1016\/j.rmed.2021.106553","volume":"187","author":"JK Lui","year":"2021","unstructured":"Lui JK, Billatos E, Schembri F. Evaluation and management of pleural sepsis. Respir Med. 2021;187:106553.","journal-title":"Respir Med"},{"issue":"9","key":"2649_CR21","doi-asserted-by":"publisher","first-page":"864","DOI":"10.3390\/jpm11090864","volume":"11","author":"G Perlepe","year":"2021","unstructured":"Perlepe G, Varsamas C, Petinaki E, et al. Discrimination of Exudative Pleural Effusions Based on Pleural Adenosine Deaminase (ADA)-C-Reactive Protein (CRP) Levels, and Their Combination: An Observational Prospective Study. J Pers Med. 2021;11(9):864.","journal-title":"J Pers Med"},{"issue":"7","key":"2649_CR22","doi-asserted-by":"publisher","first-page":"961","DOI":"10.3390\/jcm8070961","volume":"8","author":"C Cill\u00f3niz","year":"2019","unstructured":"Cill\u00f3niz C, Domined\u00f2 C, Ielpo A, et al. Risk and Prognostic Factors in Very Old Patients with Sepsis Secondary to Community-Acquired Pneumonia. J Clin Med. 2019;8(7):961.","journal-title":"J Clin Med"},{"issue":"11","key":"2649_CR23","doi-asserted-by":"publisher","first-page":"4690","DOI":"10.21037\/jtd.2017.10.96","volume":"9","author":"W Yang","year":"2017","unstructured":"Yang W, Zhang B, Zhang ZM. Infectious pleural effusion status and treatment progress. J Thorac Dis. 2017;9(11):4690\u20139.","journal-title":"J Thorac Dis"},{"issue":"3","key":"2649_CR24","doi-asserted-by":"publisher","first-page":"428","DOI":"10.3889\/oamjms.2016.091","volume":"4","author":"S Petrusevska-Marinkovic","year":"2016","unstructured":"Petrusevska-Marinkovic S, Kondova-Topuzovska I, Milenkovic Z, et al. Clinical, laboratory and radiographic features of patients with pneumonia and parapneumonic effusions. Open Access Maced J Med Sci. 2016;4(3):428\u201334.","journal-title":"Open Access Maced J Med Sci"},{"issue":"1","key":"2649_CR25","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1046\/j.1532-5415.2001.49015.x","volume":"49","author":"M Yamaya","year":"2001","unstructured":"Yamaya M, Yanai M, Ohrui T, et al. Interventions to prevent pneumonia among older adults. J Am Geriatr Soc. 2001;49(1):85\u201390.","journal-title":"J Am Geriatr Soc"},{"issue":"1","key":"2649_CR26","doi-asserted-by":"publisher","first-page":"6597","DOI":"10.1038\/s41598-021-86011-w","volume":"11","author":"JH Won","year":"2021","unstructured":"Won JH, Byun SJ, Oh BM, et al. Risk and mortality of aspiration pneumonia in Parkinson\u2019s disease: a nationwide database study. Sci Rep. 2021;11(1):6597.","journal-title":"Sci Rep"},{"issue":"1","key":"2649_CR27","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.chest.2020.06.079","volume":"159","author":"J Marin-Corral","year":"2021","unstructured":"Marin-Corral J, Pascual-Guardia S, Amati F, et al. Aspiration Risk Factors, Microbiology, and Empiric Antibiotics for Patients Hospitalized With Community-Acquired Pneumonia. Chest. 2021;159(1):58\u201372.","journal-title":"Chest"},{"issue":"3","key":"2649_CR28","doi-asserted-by":"publisher","first-page":"1900542","DOI":"10.1183\/13993003.00542-2019","volume":"54","author":"M Hassan","year":"2019","unstructured":"Hassan M, Cargill T, Harriss E, et al. The microbiology of pleural infection in adults: a systematic review. Eur Respir J. 2019;54(3):1900542.","journal-title":"Eur Respir J"},{"issue":"6","key":"2649_CR29","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1080\/17476348.2018.1475234","volume":"12","author":"L Ferreiro","year":"2018","unstructured":"Ferreiro L, Porcel JM, Bielsa S, et al. Management of pleural infections. Expert Rev Respir Med. 2018;12(6):521\u201335.","journal-title":"Expert Rev Respir Med"},{"key":"2649_CR30","first-page":"ii41","volume":"65 Suppl 2","author":"HE Davies","year":"2010","unstructured":"Davies HE, Davies RJ, Davies CW, BTS Pleural Disease Guideline Group. Management of pleural infection in adults: British Thoracic Society Pleural Disease Guideline 2010. Thorax. 2010;65 Suppl 2:ii41-53.","journal-title":"Thorax"},{"issue":"6","key":"2649_CR31","doi-asserted-by":"publisher","first-page":"e129","DOI":"10.1016\/j.jtcvs.2017.01.030","volume":"153","author":"KR Shen","year":"2017","unstructured":"Shen KR, Bribriesco A, Crabtree T, et al. The American Association for Thoracic Surgery consensus guidelines for the management of empyema. J Thorac Cardiovasc Surg. 2017;153(6):e129\u201346.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2649_CR32","unstructured":"Wang D, Shi Y. Clinical analysis of pleural effusion in senile pneumonia. Chin J Gerontol. 2013;33(20):5140\u20131. (In Chinese)."},{"issue":"4","key":"2649_CR33","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1097\/MCP.0000000000000174","volume":"21","author":"R Thomas","year":"2015","unstructured":"Thomas R, Jenkins S, Eastwood PR, et al. Physiology of breathlessness associated with pleural effusions. Curr Opin Pulm Med. 2015;21(4):338\u201345.","journal-title":"Curr Opin Pulm Med"},{"issue":"5","key":"2649_CR34","doi-asserted-by":"publisher","first-page":"1900980","DOI":"10.1183\/13993003.00980-2019","volume":"55","author":"S Muruganandan","year":"2020","unstructured":"Muruganandan S, Azzopardi M, Thomas R, et al. The Pleural Effusion And Symptom Evaluation (PLEASE) study of breathlessness in patients with a symptomatic pleural effusion. Eur Respir J. 2020;55(5):1900980.","journal-title":"Eur Respir J"},{"key":"2649_CR35","doi-asserted-by":"publisher","first-page":"816502","DOI":"10.1155\/2012\/816502","volume":"2012","author":"A Girdhar","year":"2012","unstructured":"Girdhar A, Shujaat A, Bajwa A. Management of infectious processes of the pleural space: a review. Pulm Med. 2012;2012:816502.","journal-title":"Pulm Med"},{"issue":"2","key":"2649_CR36","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/S0012-3692(15)50413-3","volume":"128","author":"CL Chung","year":"2005","unstructured":"Chung CL, Chen CH, Sheu JR, et al. Proinflammatory cytokines, transforming growth factor-beta1, and fibrinolytic enzymes in loculated and free-flowing pleural exudates. Chest. 2005;128(2):690\u20137.","journal-title":"Chest"},{"issue":"2","key":"2649_CR37","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1373\/clinchem.2015.249680","volume":"62","author":"J Zacho","year":"2016","unstructured":"Zacho J, Benfield T, Tybj\u00e6rg-Hansen A, et al. Increased Baseline C-Reactive Protein Concentrations Are Associated with Increased Risk of Infections: Results from 2 Large Danish Population Cohorts. Clin Chem. 2016;62(2):335\u201342.","journal-title":"Clin Chem"},{"key":"2649_CR38","doi-asserted-by":"publisher","first-page":"7539780","DOI":"10.1155\/2016\/7539780","volume":"2016","author":"S Izhakian","year":"2016","unstructured":"Izhakian S, Wasser WG, Fox BD, et al. The Diagnostic Value of the Pleural Fluid C-Reactive Protein in Parapneumonic Effusions. Dis Marker. 2016;2016:7539780.","journal-title":"Dis Marker."},{"issue":"4","key":"2649_CR39","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1097\/01.mcp.0000129755.79467.67","volume":"10","author":"SJ Chapman","year":"2004","unstructured":"Chapman SJ, Davies RJ. Recent advances in parapneumonic effusion and empyema. Curr Opin Pulm Med. 2004;10(4):299\u2013304.","journal-title":"Curr Opin Pulm Med"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-023-02649-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12890-023-02649-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-023-02649-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T07:02:56Z","timestamp":1700204576000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpulmmed.biomedcentral.com\/articles\/10.1186\/s12890-023-02649-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,20]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2649"],"URL":"https:\/\/doi.org\/10.1186\/s12890-023-02649-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2333941\/v1","asserted-by":"object"}]},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,20]]},"assertion":[{"value":"1 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experiments were performed in accordance with relevant guidelines and regulations. This study was approved by the Ethics Committee of the Third Affiliated Hospital of Anhui Medical University, and all participants and\/or their legal guardian(s) signed the informed consent form.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"355"}}